Patents (Details Narrative) - USD ($) |
3 Months Ended | 12 Months Ended | |
|---|---|---|---|
Mar. 31, 2018 |
Mar. 31, 2017 |
Dec. 31, 2017 |
|
| Amortization expense | $ 161,728 | $ 0 | |
| Settlement Agreement [Member] | Rio Grande Neurosciences, Inc.[Member] | |||
| Acquisition of patents | $ 4,500,000 | ||
| Patents expire period | 2024 | ||
| Patent amortization description | Patent portfolio is amortized through 2024 | ||
| X | ||||||||||
- Definition Patent amortization description. No definition available.
|
| X | ||||||||||
- Definition Patents expire period. No definition available.
|
| X | ||||||||||
- Definition The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|